[Inflammatory breast cancer: 38 cases clinical report].
Inflammatory breast cancer (IBC) is a special form of rapidly progressive breast cancer with poor prognosis. The purpose of this study was to investigate the clinical characters, treatment, and prognosis of inflammatory breast cancer. Thirty-eight patients with inflammatory breast cancer who were diagnosed and treated from March 20, 1970 to December 21, 2001 in our hospital were analyzed retrospectively. All IBC patients presented clinically with an erythematous or swollen and tender breast, no fever. The mean age of 38 patients was 45 years old. Twenty-four patients were in stage III b and 14 in stage IV. Eighteen patients received local treatment (radiotherapy or surgery) firstly and 20 patients underwent chemotherapy firstly. Median survival was 17 months. The 1 year and the 5 year survival rates were 57.7% and 14.0%, respectively. The administration of chemotherapy first improved the outcome of IBC. Earlier stage showed more favorable prognosis. Combination therapy with chemotherapy first was an effective treatment for IBC.